Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2004 Aug 3;171(3):219; author reply 221-2.
doi: 10.1503/cmaj.1040532.

Treatment of locally advanced breast cancer

Comment

Treatment of locally advanced breast cancer

Sunil Verma et al. CMAJ. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

References

    1. Shenkier T, Weir L, Levine M, Olivetto I, Whelan T, Reyno L; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ 2004;170(6):983-94. - PMC - PubMed
    1. O'Rourke MW. Rebuilding a professional practice model. The return of role-based practice accountability. Nurs Admin Q 2003;27(2):95-105. - PubMed
    1. Ellis MJ, Coop A, Singh B, Mauriac L, Llombert-Cussac A, Janicke F, et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 2001;19(18):3808-16. - PubMed
    1. Smith I, Dowsett M; IMPACT Trialists. Comparison of anastrozole vs tamoxifen alone and in combination as neoadjuvant treatment of estrogen receptor-positive (ER+) operable breast cancer in postmenopausal women: the IMPACT trial [abstract]. Breast Cancer Res Treat 2003;82 (Suppl 1):S6.
    1. Baum M, Buzdar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, et al; ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131-9. - PubMed